BALAXI PHARMACEUTICALS LIMITED — M&A Activity 2021

Nov 8, 2021

SI.No.		Particulars	Details
1.	Nameofthetargetentity,detailsinbriefsuchas		BalaxiHealthcareEl
	size,turnoveretc.		Salvador,S.ADEC.V
			(“BHES”)isa step-down
			subsidiaryofBalaxi
			PharmaceuticalsLimited
			Turnover,Size:NIL
2.	Whethertheacquisitionwouldfallwithinrelated		Yes,theacquisitionfalls
	partytransaction(s)andwhetherthepromoter/		underthedefinitionof
	promotergroup/	groupcompanieshaveany	relatedpartytransactionand
	interestintheentitybeingacquired		thetransactionwasdoneat
			arm’slengthbasis.
			TheSharesoftheacquired
			Companyweresold by
			AshishMaheshwariwhois
			theManagingDirectorand
			PromoterGroupofBalaxi
			PharmaceuticalsLimited.
Bs	Industrytowhich	theentitybeingacquired	PharmaceuticalsDistribution
	belongs		Company
4,	Objectsandeffects	`ofacquisition(includingbutnot	BalaxiHealthcareEl`
	limitedto,disclosureofreasonsforacquisitionof		Salvador,S.ADEC.Vis
	targetentity,ifits	`businessisoutsidethemainline	engagedinBalaxi’s`
	ofbusinessofthelistedentity);		pharmaceuticalformulation
			productsinElSalvador.
			Theabovesaidactivityisin
			linewiththemainobjectsof
			thisparentlistedentity
5,	Briefdetailsofany	governmentalorregulatory	Notapplicable
	approvalsrequiredfortheacquisition;
6.	Indicativetimeperiodforcompletionofthe		Theacquisitionwas
	acquisition		completedon8 November,
			2021
7s	Natureofconsideration- whethercash		ConsiderationinCash
	considerationorshareswapanddetailsofthe
	same
8.	Costofacquisition	`orthepriceatwhichtheshares	USD2,000`
	areacquired

|9.|Percentageofshareholding/ controlacquiredand| |BalaxiGlobalDMCC|shall| |---|---|---|---| ||/ornumberofsharesacquired|hold99%sharesofBHES|| |||‘0|| |10.||Briefbackgroundabouttheentityacquiredin|Dateofincorporation:|28%| ||termsofproducts/lineofbusinessacquired,date|September,2015|| ||ofincorporation,historyoflast3 yearsturnover,||| ||countryinwhichtheacquiredentityhaspresence||Countryofincorporation:El || ||andanyothersignificantinformation(inbrief);|Salvador|| |||Turnover:NIL||